Cite
APA Citation
Sorensen, S. F., Demuth, C., Weber, B., Sorensen, B. S., & Meldgaard, P. (2016). increase in soluble PD-1 is associated with prolonged survival in patients with advanced EGFR-mutated non-small cell lung cancer treated with erlotinib. Lung cancer, 100, 77–84. http://access.bl.uk/ark:/81055/vdc_100035793494.0x00003e